about
Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritisInhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulinA novel mechanism of action of tetracyclines: effects on nitric oxide synthasesPrognostic biomarkers in osteoarthritisCurrent state of therapy for pain and inflammationControversies in COX-2 selective inhibitionAssessment of coxib utilization by rheumatologists for nonsteroidal antiinflammatory drug gastroprotection prior to the coxib market withdrawalsCardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxibProstaglandin E2 synthesis and secretion: the role of PGE2 synthases17β-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-siteT1rho MRI of menisci in patients with osteoarthritis at 3 Tesla: a preliminary study.Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunityNitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis.F-spondin deficient mice have a high bone mass phenotype.Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease.Assessment of subchondral bone marrow lipids in healthy controls and mild osteoarthritis patients at 3T.Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors?Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variationsThe fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction.Controversies in COX-2 inhibitor therapy. Introduction.Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis.Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage."A system biology" approach to bioinformatics and functional genomics in complex human diseases: arthritis.The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice.Regulation of metalloproteinases and NF-kappaB activation in rabbit synovial fibroblasts via E prostaglandins and Erk: contrasting effects of nabumetone and 6MNA.Quantitative magnetic resonance imaging evidence of synovial proliferation is associated with radiographic severity of knee osteoarthritisReply: To PMID 25319745The microbiome and rheumatoid arthritisScaffold protein Disc large homolog 1 is required for T-cell receptor-induced activation of regulatory T-cell function.Long-term risks associated with biologic response modifiers used in rheumatic diseases.Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases.T1rho MRI of menisci and cartilage in patients with osteoarthritis at 3T.The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.Elevated expression of periostin in human osteoarthritic cartilage and its potential role in matrix degradation via matrix metalloproteinase-13.Periodontal disease and the oral microbiota in new-onset rheumatoid arthritisLow-grade inflammation in symptomatic knee osteoarthritis: prognostic value of inflammatory plasma lipids and peripheral blood leukocyte biomarkersPlasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis.Deletion of Panx3 Prevents the Development of Surgically Induced OsteoarthritisCytokine preconditioning of engineered cartilage provides protection against interleukin-1 insult.
P50
Q21128781-E227AA7D-06F4-469F-B367-988307B32A27Q24313406-2F9A227F-BCE4-43CE-A2BF-131AADE3DF15Q24680257-6BDA79EE-1597-4335-8C2B-EC5FEAEF8FECQ27022211-E7B2EE2A-DBAA-445F-8339-FD225AD4DD1FQ28191916-5EAA63DC-73B4-4F05-8A50-7552E05AA61AQ28193482-4DDC8EF3-7775-42EE-AD70-AFAB7BFA4581Q28199836-F933F2F4-4726-4EED-86BA-46C7187C3599Q28222097-FD5881BC-7DF8-4DBD-8AA0-3DAA5B0192D5Q28302274-27A89597-121C-4BB7-9422-95E1A1FECB92Q28728196-09616B4C-7DD8-425C-91B6-5DE26B4D25B9Q33563624-C94F3E3B-BCCE-4020-AAA4-AA2C10DFE969Q33572468-72C3A720-E9C9-41D0-AA41-130152DAE775Q33635738-DA434F23-02F6-4185-905B-246C7117F886Q33686140-EE1A19AE-7F57-46EE-82AB-214D35131C42Q33890024-D9BE28E9-2B95-422D-8BA0-5A29CAED2F26Q33995831-3CBBB910-2FCC-4700-983B-7A95145C720BQ34026155-9D067D0B-B338-400C-B7F3-6EAD42D3A9E7Q34077678-20414153-7D64-4721-9362-93AD11B6C167Q34417592-5CC3EE13-B995-4CFC-83CA-D3100442CC80Q34429140-55B16786-C4CD-449C-BA31-FDAEBB690766Q34439742-AFC2EAAF-937B-4982-ABBA-D8C854E07C85Q34791372-A3555FC6-389C-478B-941A-03426C080E25Q34809992-08D90B8E-F44B-4FC7-BFF0-80A313AEC9F1Q34998077-6E306C60-0F15-4706-8D39-5A07F28003F3Q35014661-C6BA6A94-C208-4817-98EA-0C1DA63466C1Q35047394-D53142AA-C743-4BD4-B935-6DCF0D658490Q35242231-354F2D19-4933-4910-AE7D-EE48822957EFQ35609406-17F8F4B9-34C9-4164-8EB8-09D8EBD43F8EQ35743863-C7AAD1D2-9CD3-4B1D-8BC4-5571F33B6690Q35749767-9C2EFCF9-977B-48FB-9137-B556AE189874Q35753666-17857DE8-F007-4283-85CC-12837F82CE7DQ35762027-3560FC20-8F29-4E60-AE14-B371A0F9AE49Q35819323-CE3562D5-59C8-4707-8B3A-6B2220E87D59Q36038992-ADF22B7F-4C7E-4A70-B5FB-49DC5A995A4AQ36051493-A7A5DDB9-81E4-4AE4-B331-233CD52D453AQ36191888-17DFF021-B533-48DF-B071-FF9209C92F75Q36225451-16F5193F-0F0E-4E99-BE09-BAF48B9B2398Q36242583-F3077F98-1D4B-4652-B067-9D10670E2EA6Q36436436-EA2C6180-3085-4DE8-AE20-01AF81638D33Q36439983-B747E31B-42C8-43BC-8A9E-71450E5CE2E2
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Steven B Abramson
@ast
Steven B Abramson
@en
Steven B Abramson
@es
Steven B Abramson
@nl
Steven B Abramson
@sl
type
label
Steven B Abramson
@ast
Steven B Abramson
@en
Steven B Abramson
@es
Steven B Abramson
@nl
Steven B Abramson
@sl
prefLabel
Steven B Abramson
@ast
Steven B Abramson
@en
Steven B Abramson
@es
Steven B Abramson
@nl
Steven B Abramson
@sl
P106
P21
P31
P496
0000-0002-0668-6344